Besides, the additional validation cohort (n = 138) demonstrated a significant association between SAA levels (using a cut-off value of 20.0 mg/L) and tumor responses as well as survival outcomes in aHCC patients treated with anti-PD-1-based treatment (Supplementary Fig. 4f, g and Supplementary Table 5). Here, SAA1 is linked to neoplasm.